Mason Freeman

Insider Reports History

Location
San Diego, CA
Signature
/s/ Cathy Rude, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mason Freeman:

Company Role Class Num Shares Value Price $ Report Date Ownership
CinCor Pharma, Inc. Chief Medical Officer Common Stock 0 $28.75 24 Feb 2023 By spouse
CinCor Pharma, Inc. Chief Medical Officer Common Stock 0 $28.75 24 Feb 2023 Direct
CinCor Pharma, Inc. Chief Medical Officer Stock Option (Right to Buy) 0 $8.34 24 Feb 2023 Direct

Insider Reports Filed by Mason Freeman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123005588-freeman-mason-2023-01-26 CinCor Pharma, Inc. 26 Jan 2023 1 $0 4 Chief Medical Officer 30 Jan 2023, 19:03
/report/000120919123013268-freeman-mason-2022-06-10 CinCor Pharma, Inc. 10 Jun 2022 7 -$91.26 4 Chief Medical Officer 27 Feb 2023, 16:10
/report/000120919122003188-freeman-mason-2022-01-11 CinCor Pharma, Inc. 11 Jan 2022 2 +$41,600 4 EVP Clinical Development 13 Jan 2022, 15:28
/report/000120919122002276-freeman-mason-2022-01-06 CinCor Pharma, Inc. 06 Jan 2022 0 $0 3 EVP Clinical Development 06 Jan 2022, 19:49